Dose optimization of voriconazole/anidulafungin combination against Aspergillus fumigatus using an in vitro pharmacokinetic/pharmacodynamic model and response surface analysis: clinical implications for azole-resistant aspergillosis

Therapeutic drug monitoring in the treatment of invasive aspergillosis with voriconazole in cancer patients—an evidence-based approach

(2015) Meinolf Karthaus et al.   ANNALS OF HEMATOLOGY

Combination Antifungal Therapy for Invasive Aspergillosis

(2015) Kieren A. Marr et al.   ANNALS OF INTERNAL MEDICINE

Optimization of Polyene-Azole Combination Therapy against Aspergillosis Using anIn VitroPharmacokinetic-Pharmacodynamic Model

(2015) Maria Siopi et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Caspofungin Treatment of Aspergillus fumigatus Results in ChsG-Dependent Upregulation of Chitin Synthesis and the Formation of Chitin-Rich Microcolonies

(2015) Louise A. Walker et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus

(2015) Paul E. Verweij et al.   DRUG RESISTANCE UPDATES

Susceptibility Breakpoints for Amphotericin B and Aspergillus Species in anIn VitroPharmacokinetic-Pharmacodynamic Model Simulating Free-Drug Concentrations in Human Serum

(2014) A. Elefanti et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Population Pharmacokinetic Analysis of Voriconazole and Anidulafungin in Adult Patients with Invasive Aspergillosis

(2014) Ping Liu et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Susceptibility breakpoints and target values for therapeutic drug monitoring of voriconazole and Aspergillus fumigatus in an in vitro pharmacokinetic/pharmacodynamic model

(2014) M. Siopi et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Assessment of Efficacy of Antifungals against Aspergillus fumigatus: Value of Real-Time Bioluminescence Imaging

(2013) Célimène Galiger et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pharmacokinetics of Anidulafungin in Critically Ill Patients with Candidemia/Invasive Candidiasis

(2013) Ping Liu et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Management and diagnostic guidelines for fungal diseases in infectious diseases and clinical microbiology: critical appraisal

(2013) S. Leroux et al.   CLINICAL MICROBIOLOGY AND INFECTION

In VitroCombination of Anidulafungin and Voriconazole against Intrinsically Azole-Susceptible and -Resistant Aspergillus spp.

(2012) Virginie Planche et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vitro Interaction of Voriconazole and Anidulafungin against Triazole-Resistant Aspergillus fumigatus

(2012) S. Seyedmousavi et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Combination of Voriconazole and Anidulafungin for Treatment of Triazole-Resistant Aspergillus fumigatus in anIn VitroModel of Invasive Pulmonary Aspergillosis

(2012) Adam R. Jeans et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In VitroPharmacokinetic/Pharmacodynamic Modeling of Voriconazole Activity against Aspergillus Species in a NewIn VitroDynamic Model

(2012) R. Al-Saigh et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Population Pharmacokinetic-Pharmacodynamic Analysis of Anidulafungin in Adult Patients with Fungal Infections

(2012) Ping Liu   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In vitro efficacy of the combination of voriconazole and anidulafungin against voriconazole-resistant cyp51A mutants of Aspergillus fumigatus

(2012) Suganthini Krishnan-Natesan et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Efficacy and pharmacodynamics of voriconazole combined with anidulafungin in azole-resistant invasive aspergillosis

(2012) S. Seyedmousavi et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Pharmacodynamic Effects of Simulated Standard Doses of Antifungal Drugs against Aspergillus Species in a NewIn VitroPharmacokinetic/Pharmacodynamic Model

(2011) Joseph Meletiadis et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Observational Study of the Clinical Efficacy of Voriconazole and Its Relationship to Plasma Concentrations in Patients

(2011) Peter F. Troke et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Current Role of Echinocandins in the Management of Invasive Aspergillosis

(2011) Małgorzata Mikulska et al.   Current Infectious Disease Reports

Impact of cyp51A Mutations on the Pharmacokinetic and Pharmacodynamic Properties of Voriconazole in a Murine Model of Disseminated Aspergillosis

(2010) E. Mavridou et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Wild-Type MIC Distributions and Epidemiological Cutoff Values for the Triazoles and Six Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 Document)

(2010) A. Espinel-Ingroff et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Combination Therapy in Treatment of Experimental Pulmonary Aspergillosis: In Vitro and In Vivo Correlations of the Concentration- and Dose- Dependent Interactions between Anidulafungin and Voriconazole by Bliss Independence Drug Interaction Analysis

(2009) V. Petraitis et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Combination Therapy of Advanced Invasive Pulmonary Aspergillosis in Transiently Neutropenic Rats Using Human Pharmacokinetic Equivalent Doses of Voriconazole and Anidulafungin

(2009) W. W. J. van de Sande et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vitro Susceptibility of Clinical Isolates of Aspergillus spp. to Anidulafungin, Caspofungin, and Micafungin: a Head-to-Head Comparison Using the CLSI M38-A2 Broth Microdilution Method

(2009) M. A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Susceptibility Testing of Anidulafungin and Voriconazole Alone and in Combination against Conidia and Hyphae of Aspergillus spp. under Hypoxic Conditions

(2008) S. Perkhofer et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Stimulation of Chitin Synthesis Rescues Candida albicans from Echinocandins

(2008) Louise A. Walker et al.   PLoS Pathogens

Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes

(2007) A. Pascual et al.   CLINICAL INFECTIOUS DISEASES